By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Advaxis, Inc. 

The Technology Centre of New Jersey
675 U.S. Route One, South
North Brunswick  New Jersey  08902   U.S.A.
Phone: 732-545-1590 Fax: 732-545-1084



Company News
Advaxis, Inc. To Present At International Anal Neoplasia Society Scientific Meeting 2015 2/26/2015 8:40:32 AM
Advaxis, Inc. Completes $23 Million Financing 2/18/2015 11:06:25 AM
Advaxis, Inc. Appoints Mayo Pujols Vice President, Manufacturing 2/13/2015 10:19:20 AM
Advaxis, Inc. Forms Clinical Trial Collaboration With Incyte Corporation (INCY) To Evaluate Investigational Combination Of Two Novel Cancer Immunotherapies For Early Stage Cervical Cancer 2/11/2015 7:56:49 AM
Gynecologic Oncology Group Phase 2 Study Of Advaxis, Inc.'s Lm-LLO Immunotherapy, ADXS-HPV, For The Treatment Of Persistent Or Recurrent Cervical Cancer Achieves Safety And Efficacy Criteria 1/28/2015 7:55:17 AM
Advaxis, Inc. Announces FDA Acceptance Of Its Investigational New Drug Application To Commence First-In-Human Clinical Trials Of ADXS-HER2 1/22/2015 9:25:13 AM
Advaxis, Inc. To Host Analyst & Investor Day On February 3, 2015 1/20/2015 7:52:48 AM
Advaxis, Inc. To Present At The Noble Financial Capital Markets 11th Annual Investor Conference 1/15/2015 7:23:18 AM
Advaxis, Inc. Provides 2014 Year-End Review And 2015 Outlook 1/12/2015 7:38:29 AM
Advaxis, Inc. And The GOG Foundation, Inc. To Collaborate On Global Phase 3 Clinical Trial Of ADXS-HPV In Cervical Cancer 1/7/2015 7:21:02 AM